Concepedia

Rebecca A. Cohen

RA

Statistics

Publications

3

Citations

156

H-Index

3

Active since

2013

Affiliations

University of North Carolina at Chapel Hill(Current)

UNC Lineberger Comprehensive Cancer Center

University of Colorado Anschutz Medical Campus

Rebecca A. Cohen is an author at University of North Carolina at Chapel Hill specializing in targeted therapy, mer receptor tyrosine kinase signaling, and molecular oncology.

Publications per year

2013–2016

3

Publications

3

Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia

Rachel M.A. Linger, Alisa B. Lee‐Sherick, Deborah DeRyckere et al. · Blood · 2013 · 64 citations · Full text

, , +14

Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer

Christopher T. Cummings, Rachel M.A. Linger, Rebecca A. Cohen et al. · Oncotarget · 2014 · 55 citations · Full text

, , +17

A comparison of schools: teacher knowledge of explicit code-based reading instruction

Rebecca A. Cohen, Nancy Mather, Deborah Schneider et al. · Reading and Writing · 2016 · 37 citations · Full text

, , +12

1–3 of 3